This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,176.55, is for the procurement of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a diabetes medication. The delivery order has a firm fixed price pricing type and an ultimate completion date of March 5, 2025. The contract is not designated with a set-aside requirement, indicating open competition....
This is a $1,412.96 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a medication used in the treatment of diabetes. The contract has an ultimate completion date of March 13, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a diabetes treatment medication. The contract has a firm fixed price, with a ceiling value of $1,766.20, and a period of performance through May 23, 2025. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,024.32 delivery order contract is for the supply of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a diabetes medication. The contract has an ultimate completion date of November 17, 2023 and is a firm fixed price delivery order. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a diabetes treatment medication. The award has a ceiling value of $2,082.52 and a period of performance through June 25, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,935.12 firm-fixed-price delivery order is for the supply of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a diabetes medication. The contract has a completion date of June 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,570.80 fixed-price contract is for the supply of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a type of insulin medication. The contract has an ultimate completion date of December 19, 2023 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a $1,589.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Humalog 100 unit/mL Kwikpen 3mL, a diabetes medication. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides a global pharmaceutical support vehicle through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,609.28 and a period of performance through March 8, 2023. It is for the procurement of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a pharmaceutical product used in the treatment of diabetes. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA...
This is a $7,069.86 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a prescription insulin medication. The order has an ultimate completion date of August 21, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the United States, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...